The mouse midbrain-hindbrain constriction is centrally involved in patterning of the midbrain and anterior hindbrain (cerebellum), as revealed by recent genetic studies using mice and embryological studies in chick (reviewed in [1, 2] ). This region can act as an organizer region to induce midbrain and cerebellar development. Genes such as Engrailed-1, Pax-2 and Pax-5, which are expressed in the embryonic cells that will form the midbrain and the cerebellum, are required for development of these regions. Fate-mapping experiments at early somite stages in chick have revealed that the cerebellar primordium is located both anterior and posterior to the midbrain-hindbrain constriction, whereas midbrain precursors lie more anteriorly. Fate mapping in mice has been complicated by the inaccessibility of the postimplantation embryo. Here, we report the use of a new in vivo approach involving the Cre-loxP site-specific recombination system [3] to map the fate of cells in the mouse midbrain-hindbrain constriction. We show that cells originating in the mouse dorsal midbrain-hindbrain constriction during embryonic days 9-12 contribute significantly to the medial cerebellum and colliculi. Our data demonstrate the feasibility of using a recombinase-based lineage-tracing system for fate mapping in the mouse. 
Results and discussion
The strategy [4] we used for fate mapping cells of the mouse embryonic midbrain-hindbrain constriction involved creating two types of transgenic mice and breeding them to obtain double transgenics for analysis (Figure 1a) . One line (En2-cre mice) expresses Cre recombinase under the control of an Engrailed-2 (En2) genomic regulatory fragment [5, 6] that directs expression to the embryonic midbrain-hindbrain constriction region. Cre recombinase from bacteriophage P1 catalyzes site-specific recombination between loxP DNA sites [3] and this system has been shown to be functional in transgenic mice [7, 8] . The second, 'reporter', line (cβ-STOP-lacZ) has a loxP-stop-oftranscription/translation-loxP-lacZ (STOP-lacZ) cassette [8] driven by regulatory sequences from the widely expressed chick β-actin gene ( Figure 1c and see Supplementary material published with this paper on the internet). On crossing heterozygous En2-cre and reporter mice, one quarter of the progeny should consist of double transgenics. Only cells that express Cre from the En2 regulatory elements should undergo recombination between the loxP sites of the reporter construct, excising the STOP and permitting lacZ expression. As the Cre-mediated excision is cell heritable, the marked cells and all their progeny should express lacZ at later stages even after cre is no longer expressed. Thus, βgal staining in the brains of adult doubletransgenic animals should reveal the progeny of all cells that expressed cre transiently during development.
The cβ-STOP-lacZ reporter mice were made by zygote injection and random integration of the STOP-lacZ transgene. Potential readthrough of lacZ expression in the absence of Cre was examined by analyzing lacZ expression. Some cβ-STOP-lacZ mice exhibited scattered weak blue staining in the hippocampus and less frequently in the deep layers of the cortex adjacent to the corpus collosum ( Figure 2a ) whereas no staining was observed in the brains of control CD1 mice. As this nonspecific staining was weak and not in the midbrain-hindbrain region, it was not considered in the fate mapping.
As a positive control, reporter mice were mated with mice transgenic for a human cytomegalovirus promoter driving cre (CMV-cre) to determine the potential for lacZ expression. CMV-cre mice can express cre in all cells throughout the two-cell to eight-cell stages (data not shown). Therefore, double transgenics should reveal all possible sites of lacZ expression in the reporter strain. Sagittal sections of brains of double-transgenic adults revealed lacZ expression throughout the brain in the majority of specimens ( Figure 2b ,c and see Supplementary material). The exact pattern of lacZ expression, however, varied even within a single litter. This variability most probably reflects the multicopy nature of the reporter transgene array, which permits a variety of recombination events that could result in different levels of lacZ expression and/or regional expression patterns. About 20% of double transgenics, however, exhibited lacZ expression in all brain neurons ( Figure 2c ). Construction of a reporter line containing a single transgene would resolve this complication. We attempted to create such a single-copy STOP-lacZ reporter mouse using a 'knock-in' gene-targeting approach [9] into exon 2 of the endogenous mouse β-actin gene (see Supplementary material). However, this failed to produce targeted animals that could express lacZ ubiquitously after Cre-mediated excision of the STOP sequence (see Supplementary material).
Adult CMV-cre;cβ-STOP-lacZ mice consistently showed strong lacZ expression in the olfactory bulbs, cortex and hippocampus. Expression in most midbrain and hindbrain regions was also prominent, with the tectum (inferior and superior colliculi) staining in 70%, the cerebellum in 80%, and the anterior hindbrain in 75% of adults. The ventral midbrain (tegmentum), however, expressed β-galactosidase (βgal) in only 30% of double transgenics. These results demonstrate that cβ-STOP-lacZ mice can be used to map the fate of cells in all areas of the brain except the tegmentum if three or more animals are analyzed and the cumulative expression pattern of the animals is used.
Embryonic day (E) 8.5 and 9.5 CMV-cre;cβ-STOP-lacZ embryos exhibited at most only scattered lacZ-positive cells across the head and in the myoblasts, heart and somites ( Figure 2d ). By E14.5, however, embryos (n = 7) expressed lacZ in a pattern suggesting that all post-mitotic neurons can express lacZ (Figure 2e ). Outside of the brain, lacZ expression was detected in adults in the spinal cord, dorsal root ganglia, sympathetic ganglia, heart and some skeletal muscle, but not in other tissues (data not shown).
Our previous studies [5, 6] Whole-mount RNA in situ hybridization with a cre antisense probe confirmed that all five En2-cre lines express cre in a similar narrow dorsal domain in the midbrain-hindbrain constriction at E9.5 ( Figure 3a ). Three lines (3, 4, 11) were analyzed in more detail at E8.5 and E10.5. Cre expression was never detected at E8.5 (5-10 somite stage; data not shown). At E10.5, cre expression in each line was weaker than at E9.5 and was detected in a more restricted dorsal domain ( Figure 3b and data not shown). Sagittal section RNA in situ analysis with a cre probe did not detect expression in the brains of E14.5 embryos from three En2-cre lines (4, 6, 11) , although a control En2 probe confirmed the integrity of the experiment.
To identify the group of cells derived from the creexpressing cells in En2-cre mice, each of the five En2-cre transgenic lines was mated with cβ-STOP-lacZ mice and the bisected heads of double-transgenic E14.5 embryos stained for βgal ( Figure 4 ). As cre is not detected in the brain at E14.5 in our En2-cre transgenic mice, the specific subset of midbrain and cerebellar neurons that express lacZ represents the group of post-mitotic cells that derive from the cre-expressing precursor cells present in the dorsal midbrain-hindbrain constriction during E9-E12. Expression of lacZ at E14.5 in En2-cre;cβ-STOP-lacZ embryos was much more restricted than that seen in control CMV-cre;cβ-STOP-lacZ double-transgenic embryos ( Figure 2e ). Despite some variability in the extent of staining between animals, lacZ expression was observed in the cerebellum, tectum and ventral midbrain of all En2-cre;cβ-STOP-lacZ embryos ( Figure 4 and see Supplementary material). Embryos derived from En2-cre line 4 exhibited additional staining in the forebrain and, from line 3, in the ventral diencephalon and hindbrain. As this staining was not consistent among all the lines, it probably reflects ectopic cre expression due to positional effects at the sites of transgene insertion.
To determine the fate of cre-expressing cells in the dorsal midbrain-hindbrain constriction, En2-cre;cβ-STOP-lacZ F1 adult brains were examined. All five En2-cre lines exhibited staining in the cerebellum, tectum and hippocampus ( Figure 4 and see Supplementary material). Line 3 also exhibited lacZ expression in the hypothalamus and hindbrain and line 4 in the telencephalon, which probably reflects the ectopic lacZ expression seen in E14.5 embryos with these two En2-cre lines. Lines 3, 4 and 22 had scattered cells expressing lacZ in the tegmentum, as did the double transgenics with all the En2-cre lines at Brief Communication 667
Figure 3
The En2-cre transgene is expressed specifically in the embryonic dorsal mid-hindbrain junction. Expression of cre was examined by whole-mount RNA in situ hybridization with a cre antisense probe in (a) E9.5 (lateral view) and (b) E10.5 (dorsal view) embryos from the En2-cre transgenic lines indicated. Arrows identify regions of cre expression. βgal staining in the cerebellum of the five En2-cre lines in double transgenics varied in its medio-lateral extent, with all the lines expressing at the midline, with varying degrees of mosaic expression laterally ( Figure 4 ). In the colliculi, lacZ expression was strongest in more medial and posterior regions as well as having different rostral borders in each En2-cre line. As the staining patterns were consistent between animals carrying a particular En2-cre transgene at both E14.5 and in the adult, the different staining patterns in each transgenic line probably reflect slight differences in cre expression due to position effects. In the chick, granule cells are only derived from the hindbrain at early somite stages, whereas Purkinje cells are derived from the midbrain and cerebellum [10, 11] . We therefore analyzed sections of double transgenics from lines 6 and 11 (n = 4) to determine whether the spatial distribution of both cell types was the same. In all medial to lateral sections analyzed, lacZ-expressing Purkinje and granule cells were adjacent to each other, with no consistent areas where one or the other cell type expressed lacZ alone.
Our studies indicate that murine cells located in the dorsal midbrain-hindbrain constriction during E9-E12 can populate large regions of the murine colliculi and cerebellum. The En2-cre lines involving smaller areas of the adult brain marked cells in the medial region of the cerebellum as well as cells scattered in the inferior colliculus, whereas one of the En2-cre lines (line 3) marked the medial cerebellum and much of the lateral regions, as well as most of the colliculi. A recent study of cell lineages in the mouse cerebellum demonstrated that, as in chick, granule cells are not clonally related to Purkinje cells, and that all large clones populated the cerebellum along the entire anteroposterior length and that different clones marked a medial or a lateral domain of the cerebellum [12] . Our En2-cre lines 6, 11 and 22 appear to mark a similar medial domain of both Purkinje and granule cells. None of our lines marks only a lateral domain, but line 3 marks both the medial and lateral domains. In the clonal analysis, it was not possible to determine when and where each initial cell was marked, and so it is not feasible to derive a fate map from such studies. Our fate-mapping analysis indicates that the medial Purkinje cell clones observed in the lineage study came from the midbrain-hindbrain constriction region.
Additional cre transgenic lines that further divide the midbrain and hindbrain regions, and a reporter line that is expressed in the embryonic neuroepithelium, will enable a more precise fate map to be established in mouse. The approach demonstrated in the present study with the cβ-STOP-lacZ transgenic reporter line can now be used to build fate maps of other regions of the brain using different promoters to drive the expression of cre in specific spatial domains of the early embryonic brain. Fate maps of embryonic cells in other regions of the nervous system and in the heart and skeletal muscles where this reporter transgene is expressed could also be derived.
Supplementary material
A detailed Materials and methods section for the experiments described here and detailed tables summarizing the transgenic expression patterns are published together with this paper on the internet.
Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system 
Materials and methods

Construction of plasmids
The En2-cre transgene was constructed from the plasmids pB9 [S1], pKS(Sal) 2 The cβ-STOP-lacZ reporter transgene consists of the following elements, in 5′ to 3′ order: (1) a 3.1 kb fragment of the chick β-actin promoter including the first exon, first intron, and the 5′ untranslated portion of the second exon; (2) a loxP site; (3) a STOP sequence [S4] containing an inverted his3 element with a false translational stop, and an SV40 splice donor/poly(A)-addition site; (4) a second loxP site; (5) the lacZ coding sequence containing a nuclear localization signal (nlacZ); (6) the 3′ untranslated region (UTR) of the mouse protamine-1 (mPrm-1) gene, included to improve expression of the transgene. Briefly, this construct was generated by first cloning the SalI/BglII fragment of the plasmid pnlacF into the SmaI site of plasmid pBSlox 2 , thereby placing the nlacZ coding and mPrm-1 3′ UTR sequences downstream of tandem loxP sites separated by a polylinker region containing XhoI, BglII and HindIII sites, in an intermediate plasmid called pX 2 Z3 (E.M., unpublished). A 1.3 kb BamHI-HindIII fragment containing the STOP sequence from plasmid pBS241 [S4] was then inserted between the BglII and HindIII sites flanked by the tandem loxP sites in pX 2 Z3, to generate pXSTOPXnZ. Finally, a 3.1 kb SalI-XbaI fragment from the plasmid pβact-1 containing the chick β-actin promoter was cloned between SalI and XbaI sites located upstream of the 5′-most loxP sites in pXSTOPXnZ, to generate the final plasmid pβact-XSTOPX-nlacZ (referred to in this study as cβ-STOP-lacZ). Transgenic mice were generated by injecting the 8.2 kb SalI-Asp718 fragment from this plasmid into zygotes. A detailed restriction map of this plasmid is available on request.
To generate the mouse (m) β-STOP-lacZ targeting vector to insert a (loxP-STOP-loxP-nlacZ) reporter cassette into the second exon of the mouse β-actin locus, the following steps were performed, in brief. A 3.9 kb SalI-XhoI fragment containing the 3′ arm of the mouse β-actin gene was cloned into SmaI-digested pUC19, to generate pUC-Act3′-2. In parallel, a fragment containing the bacterial neomycin-resistance gene (neo r ) followed by the SV40 intron and three consecutive SV40 poly(A)-addition sites [S5] was inserted between the tandem loxP sites in the plasmid pX 2 Z3, to generate the intermediate pXneoXnZ. The 3′ β-actin arm, with the EcoRV site inactivated, was then transferred from pUC-Act3′ to a position immediately downstream of the lacZ coding sequence, to generate pXneoXnZAc3′. A fragment containing the PGK-tk cassette fused to the 5′ arm of the mouse β-actin gene (a 1.2 kb SalI-XbaI fragment with the initiator codon deleted) was ultimately inserted upstream of the 5′-most loxP site to generate the final targeting construct. The 5′ and 3′ arms of the mouse β-actin gene were the generous gift of Richard Behringer.
Transgenic CMV-cre transgenic mice were generated from a linearized fragment derived from plasmid pBS185 (the generous gift of Brian Sauer), which contains the CMV promoter-enhancer, the cre coding sequence, and introns and the 3′ UTR from the metallothionein-I (MT-I) gene. The position of insertion and number of transgene inserts (30-40) in line 32-3 does not appear to be deleterious, as homozygous cβ-STOP-lacZ mice appear healthy.
Screening of transgenic mice
Transgenic mice were generated [S6] and identified by Southern blot analysis. For En2-cre mice, tail DNA was digested with EcoRI and probed with a 683 bp BamHI-MluI cre-containing fragment from pBS185. For cβ-STOP-lacZ mice, tail DNA was digested with EcoRV and probed with a 1.1 kb EcoRI-EcoRV nlacZ-containing fragment from the original transgene vector. After founders were established, genotyping was usually done by three-primer PCR. Yolk sac or tail DNA from En2-cre (0.18 µg) or cβ-STOP-lacZ (0.06 µg) was amplified for 27 cycles (1 min at 94°C, 1 min at 62°C, 1.5 min at 72°C) on a thermal cycler. The 5′ cre primer was 5′-CATTTCGTGATGAATGCCAC-3′, the 5′ endogenous mouse metallothionein primer (which excludes sequence in common with the mouse metallothionein polyadenylation site downstream of cre) was 5′-CCGTAGCTCCAGCTTCACC-3′, and the common 3′ MT primer was 5′-ACTTGCAGTTCTTGCAGGC-3′. The 5′ lacZ primer was 5′-GGTCGCTACCATTACCAGTTG-3′, the 5′ endogenous mouse protamine-1 primer (which excludes sequences in common with the mouse protamine-1 polyadenylation site downstream of lacZ) was 5′-AGGTGGTGTCCCCTGCTC-3′ and the common 3′ mouse protamine-1 primer was 5′-ACGCAGGAGTTTTGATGGAC-3′. Half of the 20 µl reaction volume was analyzed on a 2% agarose gel.
With the En2/cre primers, the wild-type allele is indicated by a 588 bp band, whereas the En2/cre transgene produces a 668 bp band. With the cβ-STOP-lacZ primers, wild type has a 332 bp band, whereas the cβ-STOP-lacZ transgene produces a 349 bp band.
Detection of β-galactosidase activity E9.5 embryos were dissected into cold phosphate-buffered saline (PBS) and transferred as dissected into PBS on ice. When all embryos were dissected, they were changed into cold paraformaldehyde (PFA) 4%/PBS and rocked at 4°C for 1 h. After fixation, embryos were washed three times for 30 min with wash buffer (2 mM MgCl 2 , 0.02% Nonidet-P40, 0.1 M phosphate buffer pH 7.3) once at 4°C and twice at room temperature. Embryos were then transferred to prewarmed X-gal solution (0.1 mg/ml X-gal/DMF, 2.12 mg/ml potassium ferrocyanide and 1.64 mg/ml potassium ferricyanide in wash buffer) and placed at 37°C overnight. The next day, they were washed twice with PBS then placed in 10% formalin at 4°C overnight. Embryos were then washed twice with PBS and stored in 70% ethanol at 4°C.
E14.5 embryos to be stained were dissected into cold PBS, their heads pinched off with forceps as far down the shoulders as possible without taking the arms, and transferred as dissected into 50 ml PBS on ice (≤ 6 heads per tube). When all embryos were dissected, they were changed into cold PFA 4%/PBS and allowed to rock at 4°C for 4 h. Following fixation, embryo heads were either cut sagittally at the midline with a scalpel blade and washed in PBS or were transferred into cold 30% sucrose/PBS and allowed to sit at 4°C overnight until they sank. Such embryo heads were dried on lens paper and mounted in OCT. A cryostat was used to cut sagittally to midline. Three to four head-containing blocks were placed in 50 ml tubes and allowed to rock in 40 ml of wash buffer at room temperature for 15 min and then in fresh 40 ml wash buffer for 30 min. Three to four brains, cut with a scalpel or cryostat, were then put into 15-20 ml of prewarmed X-gal solution and allowed to stand covered at 37°C overnight. After one PBS rinse, heads were placed in 40 ml 10% formalin for 4 h to overnight. Heads were then rinsed with PBS and stored in 70% ethanol at 4°C.
Adult brains were dissected out dry, cooled at 4°C for 3 min and sliced sagittally into 2 mm slices. The slices were transferred to room temperature PFA 4%/PBS and then placed on ice until all brains were finished. The brain slices were changed into fresh cold PFA 4%/PBS and placed at 4°C for 1 h: 15 min standing, 45 min rocking. After fixation, brains were washed three times for 30 min with wash buffer, once at 4°C and twice at room temperature. They were then changed into prewarmed X-gal solution and placed at 37°C overnight. The next day, brains were washed twice with PBS then placed in 10% formalin at 4°C overnight. Brains were then washed twice with PBS and stored in 70% ethanol at 4°C.
RNA in situ hybridization
Whole-mount RNA in situ procedures were carried out according to Conlon and Rossant [S7] .
Production of targeted mice: ES cell culture, screening for homologous recombinants and chimera production
The mβ-STOP-lacZ targeting construct was generated by homologous recombination in embryonic stem (ES) cells of the mβ-STOP-lacZ targeting construct into the second exon of the mouse β-actin gene [S8] . The mβ-STOP-lacZ targeting construct was released from the plasmid by SalI digestion and then introduced into ES cells by electroporation. The R1 ES cell line [S9] was propagated, electroporated and selected as described by Wurst and Joyner [S8] . After positive-negative selection with G418/ganciclovir-containing media, surviving ES cell clones were analyzed by genomic Southern blot analysis using two external probes, a 5′ 0.37 kb EcoRV fragment and a 3′ 0.48 kb XhoI-BamHI fragment. Genomic DNA digested with EcoRV and probed with the 5′ probe gave a 1.4 kb wild-type and 5.3 kb mutant fragment, and probed with the 3′ probe gave a 8.2 kb wild-type and 12.5 kb mutant band. Southern blot analysis identified 3 of 55 neomycin-and ganciclovir-resistant clones as being correctly targeted. Two of the targeted lines were used to produce chimeras through aggregration with morulae [S10] . Three chimeras from one line were found to transmit the embryonic stem cell genotype to heterozygous mice after breeding with CD1 mice, referred to as β-actin neolacZ . Homozygous β-actin neolacZ mice were never obtained, suggesting that disruption of the β-actin gene results in embryonic lethality. Tail or yolksac DNA (~10 µg) was digested with EcoRV and run on a 1% agarose gel. A 370 bp EcoRV-XhoI β-actin-containing fragment of the original targeting construct was used as the hybridization probe.
To determine the potential for lacZ expression from the β-actin locus, β-actin neolacZ mice were mated with mice carrying a CMV-cre transgene, a different line than the one used to study the STOP-lacZ mice. From this cross, 4 of 11 progeny were identified as carrying both the targeted β-actin allele and the CMVcre construct. Two of the double transgenics carried the β-actin lacZ allele generated by Cre-mediated deletion of neo r in most cells. One of the β-actin lacZ females was crossed with a CD1 male and killed when the embryos reached E11.5. Various tissues were removed from the mother and half of each adult tissue was used for either βgal staining or northern blot analysis with a lacZ probe. As a control for lacZ expression, tissues from a mouse carrying the ROSA26 gene trap insertion that expresses lacZ ubiquitously [S11] were also analyzed. Whereas every cell type in all ROSA tissues analyzed expressed lacZ, only the brain of the adult β-actin lacZ mouse showed any staining, primarily limited to the cortex, granular cells of the cerebellum and hippocampus (data not shown). Northern blot analysis did not detect a lacZ transcript in any of the β-actin lacZ tissues whereas a transcript was detected in all of the ROSA26 tissues (data not shown). The fact that a lacZ transcript was not detected in the brain tissues of the β-actin lacZ mouse in spite of βgal activity probably reflects the differing sensitivities of the two assays. Five of the nine E11.5 embryos recovered from the β-actin lacZ mouse carried the β-actin lacZ allele and they exhibited only scattered βgal staining in cells in the heart and, in one embryo, also in the spinal cord (data not shown). Similar results were obtained with embryos from the other β-actin lacZ mouse. Targeting elsewhere in the β-actin gene might produce more robust lacZ expression, although at least one other attempt to produce a gene trap in the first intron did not result in ubiquitous expression [S12] . (n = 8) (n = 8) (n = 4) (n = 8) (n = 3)
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Brain region Cortex  100  50  50  100  100  100  Ventral telencephalon  100  12  88  100  100  100  Dorsal diencephalon  100  12  88  100  100  100  Ventral diencephalon  100  12  88  100  100  100  Superior colliculus  100  100  50  50  62  38  100  Inferior colliculus  100  100  50  50  62  38  100  Tegmentum  100  50  50  50  50  12  88  100  Cerebellum  100  50  50  25  75  12  88  33  67  Metencephalon  100  62  38  25  75  100  100 + denotes strong staining in most or all cells; ± denotes mosaic staining; -denotes no or few cells staining. (n = 4) (n = 3) (n = 5) (n = 4) (n = 4) 
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